Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Barendregt

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. There's more to heart disease than cholesterolL Bonneux, J J Barendregt
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1999
[Primary prevention remains expensive, notwithstanding the consensus on lowering serum cholesterol levels]L Bonneux, J J Barendregt
BMJ (Clinical Research Ed.)|November 13, 1993
Gastric cancer. No proof that early diagnosis reduces mortalityL Bonneux, J J Barendregt
Journal of Clinical Epidemiology|April 1, 1992
Timeless epidemiology or history cannot be ignoredL J Gunning-Schepers, J J Barendregt
Nederlands Tijdschrift Voor Geneeskunde|March 3, 1990
[Do not underestimate prevention!]L J Gunning-Schepers, J J Barendregt
Epidemiology (Cambridge, Mass.)|January 1, 1995
Shift in body mass index distributions due to height lossL J Launer, J J Barendregt, T Harris
Epidemiology (Cambridge, Mass.)|April 28, 2000
An indirect estimate of the incidence of non-insulin-dependent diabetes mellitusJ J Barendregt, C A Baan, L Bonneux
Lancet (London, England)|July 12, 1997
Global burden of diseaseJ J Barendregt, W J Nusselder, L Bonneux
Journal of Epidemiology and Community Health|April 16, 2005
Quantitative health impact assessment: current practice and future directionsJ L Veerman, J J Barendregt, J P Mackenbach
Tobacco Control|January 31, 2009
Predicting the future prevalence of cigarette smoking in Australia: how low can we go and by when?C E Gartner, J J Barendregt, W D Hall
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|April 16, 1994
Ischaemic heart disease and cholesterol. There's more to heart disease than cholesterolL Bonneux, J J Barendregt
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1999
[Primary prevention remains expensive, notwithstanding the consensus on lowering serum cholesterol levels]L Bonneux, J J Barendregt
BMJ (Clinical Research Ed.)|November 13, 1993
Gastric cancer. No proof that early diagnosis reduces mortalityL Bonneux, J J Barendregt
Journal of Clinical Epidemiology|April 1, 1992
Timeless epidemiology or history cannot be ignoredL J Gunning-Schepers, J J Barendregt
Nederlands Tijdschrift Voor Geneeskunde|March 3, 1990
[Do not underestimate prevention!]L J Gunning-Schepers, J J Barendregt
Epidemiology (Cambridge, Mass.)|January 1, 1995
Shift in body mass index distributions due to height lossL J Launer, J J Barendregt, T Harris
Epidemiology (Cambridge, Mass.)|April 28, 2000
An indirect estimate of the incidence of non-insulin-dependent diabetes mellitusJ J Barendregt, C A Baan, L Bonneux
Lancet (London, England)|July 12, 1997
Global burden of diseaseJ J Barendregt, W J Nusselder, L Bonneux
Journal of Epidemiology and Community Health|April 16, 2005
Quantitative health impact assessment: current practice and future directionsJ L Veerman, J J Barendregt, J P Mackenbach
Tobacco Control|January 31, 2009
Predicting the future prevalence of cigarette smoking in Australia: how low can we go and by when?C E Gartner, J J Barendregt, W D Hall
Pageof 4